Pricing Log in Create free account

MiNK Therapeutics, Inc. (INKT) vs Verrica Pharmaceuticals Inc. (VRCA)

MiNK Therapeutics, Inc. and Verrica Pharmaceuticals Inc. are both Biotechnology companies. MiNK Therapeutics, Inc. and Verrica Pharmaceuticals Inc. are of similar size ($53.1M and $51.3M). MiNK Therapeutics, Inc. has the higher net margin (0.00% vs −102.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, MiNK Therapeutics, Inc. leads on 7 and Verrica Pharmaceuticals Inc. on 5.

Valuation

Metric INKT VRCA Biotechnology median
P/E n/m n/m 10.60
P/S n/m 2.26 9.40
P/B n/m 15.93 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 2.33 9.02
Earnings yield (23.19%) (51.86%) (32.88%)
Free cash flow yield (13.28%) (19.81%) (23.13%)

Profitability

Metric INKT VRCA Biotechnology median
Gross margin 0.00% 85.89% 68.51%
Operating margin 0.00% (93.59%) 0.00%
Net margin 0.00% (102.84%) 0.00%
Free cash flow margin 0.00% (44.02%) 0.00%
Return on equity 57.94% 473.29% (51.96%)
Return on assets (187.78%) (83.02%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric INKT VRCA Biotechnology median
Revenue growth (TTM) — 106.21% 6.76%
EPS growth (last fiscal year) (2.45%) 88.65% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INKT VRCA Biotechnology median
Debt to equity 0.00 0.18 0.00
Current ratio 1.23 1.45 4.97
Net debt to EBITDA 1.07 2.59 1.01

Dividend

Metric INKT VRCA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric INKT VRCA Biotechnology median
Market cap 51.28m 53.08m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack